MediWound Management
Management criteria checks 1/4
MediWound's CEO is Ofer Gonen, appointed in Jun 2022, has a tenure of 1.92 years. total yearly compensation is $1.13M, comprised of 42.4% salary and 57.6% bonuses, including company stock and options. directly owns 1.07% of the company’s shares, worth $1.71M. The average tenure of the management team and the board of directors is 1.6 years and 1.8 years respectively.
Key information
Ofer Gonen
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | 42.4% |
| CEO tenure | 1.9yrs |
| CEO ownership | 1.1% |
| Management average tenure | 1.6yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25%
May 07
We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely
Feb 28Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking
Feb 01MediWound Ltd.'s (NASDAQ:MDWD) 26% Share Price Surge Not Quite Adding Up
Dec 18MediWound Ltd. (NASDAQ:MDWD) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Sep 29MediWound's NexoBrid for thermal burns in children gets EMA review
Sep 20Need To Know: Analysts Just Made A Substantial Cut To Their MediWound Ltd. (NASDAQ:MDWD) Estimates
Aug 11MediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $4.67M misses by $0.61M
Aug 09MediWound refiling for NexoBrid to treat severe thermal burns gets FDA review
Aug 03MediWound adds 13% after favorable data for ulcer candidate
Jul 07MediWound taps Tzvi Palash as COO
Jun 30Is MediWound (NASDAQ:MDWD) In A Good Position To Deliver On Growth Plans?
Jun 24Here's Why We're Watching MediWound's (NASDAQ:MDWD) Cash Burn Situation
Dec 07MediWound: Adjusting My Strategy After NexoBrid CRL
Jul 28MediWound completes enrollment for interim assessment of mid-stage EscharEx study
Jun 09MediWound EPS beats by $0.02, beats on revenue
May 05We're Hopeful That MediWound (NASDAQ:MDWD) Will Use Its Cash Wisely
May 04MediWound: Managing A Position Ahead Of NexoBrid's PDUFA
May 02Update: MediWound (NASDAQ:MDWD) Stock Gained 84% In The Last Year
Feb 19
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$1m | US$480k | -US$7m |
| Sep 30 2023 | n/a | n/a | -US$12m |
| Jun 30 2023 | n/a | n/a | -US$14m |
| Mar 31 2023 | n/a | n/a | -US$20m |
| Dec 31 2022 | US$850k | US$253k | -US$20m |
Compensation vs Market: Ofer's total compensation ($USD1.13M) is about average for companies of similar size in the US market ($USD1.58M).
Compensation vs Earnings: Ofer's compensation has increased whilst the company is unprofitable.
CEO
Ofer Gonen (50 yo)
1.9yrs
Tenure
US$1,133,000
Compensation
Mr. Ofer Gonen, B.Sc. MA Economic & Finance, serves as Chief Executive Officer at MediWound Ltd. since June 30, 2022. He was Chief Executive Officer of Clal Biotechnology Industries Ltd.from March 7, 2017...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.9yrs | US$1.13m | 1.07% $ 1.7m | |
| Chief Financial Officer | less than a year | US$244.00k | no data | |
| Executive VP | 10.4yrs | US$379.00k | 0% $ 0 | |
| Chief Research & Development Officer | 10yrs | US$479.00k | 0% $ 0 | |
| Co-Founder | 23.3yrs | US$817.00k | 2.91% $ 4.7m | |
| COO & Chief Commercial Officer | less than a year | no data | no data | |
| Executive Vice President of Strategy & Corporate Development | 1.2yrs | no data | no data | |
| Chief Medical Officer | 1.3yrs | no data | no data |
1.6yrs
Average Tenure
53yo
Average Age
Experienced Management: MDWD's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 7yrs | no data | 0% $ 0 | |
| Executive Independent Chairman | 1.8yrs | no data | 0% $ 0 | |
| Independent Director | 4.1yrs | no data | 0% $ 0 | |
| Independent Director | 7yrs | no data | 0% $ 0 | |
| Member of Strategic Advisory Board | 1.6yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Strategic Advisory Board | 1.6yrs | no data | no data |
1.8yrs
Average Tenure
69yo
Average Age
Experienced Board: MDWD's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.